Literature DB >> 19003638

Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia.

Nina K Harsem1, Kristin Braekke, Tale Torjussen, Kristian Hanssen, Anne Cathrine Staff.   

Abstract

OBJECTIVE: Preeclampsia (PE) and diabetes mellitus (DM) are associated with oxidative stress. DM is complicated with formation of advanced glycation end products (AGEs), which are associated with oxidative stress. We hypothesized that elevated serum AGE would be found in pregnancies complicated by PE or DM.
METHODS: Circulating AGEs, 8-isoprostane, vitamin E, and antioxidant capacity were analyzed from study patients.
RESULTS: Serum AGE was elevated both in patients with type 1 DM and gestational DM, but not in PE, compared with controls. 8-isoprostane was elevated in patients with type 1 DM and PE compared with controls.
CONCLUSION: AGEs and 8-isoprostane are not elevated in parallel in pregnancies complicated with PE or DM, suggesting biological heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19003638     DOI: 10.1080/10641950802000968

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  9 in total

1.  Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?

Authors:  Anne E Barden; Tomas B Corcoran; Emilie Mas; Thierry Durand; Jean-Marie Galano; L Jackson Roberts; Michael Paech; Neil A Muchatuta; Michael Phillips; Trevor A Mori
Journal:  Antioxid Redox Signal       Date:  2011-09-29       Impact factor: 8.401

2.  Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes.

Authors:  Y Yu; K F Hanssen; V Kalyanaraman; A Chirindel; A J Jenkins; A J Nankervis; P A Torjesen; H Scholz; T Henriksen; B Lorentzen; S K Garg; M K Menard; S M Hammad; J A Scardo; J R Stanley; M Wu; A Basu; C E Aston; T J Lyons
Journal:  BJOG       Date:  2012-08-20       Impact factor: 6.531

3.  Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes.

Authors:  Vendula Bartáková; Anna Pleskačová; Katarína Kuricová; Lukáš Pácal; Veronika Dvořáková; Jana Bělobrádková; Marie Tomandlová; Josef Tomandl; Kateřina Kaňková
Journal:  Glycoconj J       Date:  2016-06-10       Impact factor: 2.916

Review 4.  Serum vitamin E level and gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Foruzan Sharifipour; Parvin Abedi; Shahla Faal Ciahkal; Shayesteh Jahanfar; Zeynab Mohaghegh; Maryam Zahedian
Journal:  J Diabetes Metab Disord       Date:  2020-07-04

5.  Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.

Authors:  Thomas J van 't Erve; Maria B Kadiiska; Stephanie J London; Ronald P Mason
Journal:  Redox Biol       Date:  2017-03-28       Impact factor: 11.799

6.  Influence of gestational diabetes on the activity of δ-aminolevulinate dehydratase and oxidative stress biomarkers.

Authors:  Fabiane Rodrigues; Leidiane de Lucca; Walter S Neme; Thissiane de Lima Gonçalves
Journal:  Redox Rep       Date:  2017-11-17       Impact factor: 4.412

7.  Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.

Authors:  Daniel P Jacobsen; Ragnhild Røysland; Heidi Strand; Kjartan Moe; Meryam Sugulle; Torbjørn Omland; Anne Cathrine Staff
Journal:  Acta Diabetol       Date:  2022-07-07       Impact factor: 4.087

8.  Proteome profiling of gestational diabetes mellitus at 16-18 weeks revealed by LC-MS/MS.

Authors:  Xiaoting Liu; Jingru Sun; Xinyu Wen; Jinyan Duan; Dandan Xue; Yuling Pan; Jinghua Sun; Wei Zhang; Xiaoliang Cheng; Chengbin Wang
Journal:  J Clin Lab Anal       Date:  2020-06-15       Impact factor: 2.352

9.  The relationship between advanced glycation end products and gestational diabetes: A systematic review and meta-analysis.

Authors:  Mekonnen Sisay; Dumessa Edessa; Tilahun Ali; Abraham Nigussie Mekuria; Alemu Gebrie
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.